Literature DB >> 25223592

Immunoblastic follicular lymphoma: a very unusual transformation of low-grade follicular lymphoma.

Shereen Gheith1, Dennis Cornfield2, Weiyi Chen3, Pal Singh-Kahlon4, Basil Ahmed5.   

Abstract

A 73-year-old man, in clinical remission 17 years after radiation therapy for a localized low-grade follicular lymphoma (FL), developed extensive lymphadenopathy, ascites, and splenomegaly with splenic masses. Axillary lymph node biopsy showed FL composed of nodules of centrocytes side by side with nodules of immunoblasts rather than centroblasts. Immunophenotyping revealed conventional FL markers (BCL-2, BCL-6, and CD10) as well as MUM-1 in the immunoblastic component, suggesting postgerminal center differentiation. Fluorescence in situ hybridization showed t(14;18) in both centrocytic and immunoblastic components and a copy gain of BCL-6 predominantly in the immunoblastic component. Areas of centrocytic and of immunoblastic nodules were macrodissected separately and underwent molecular evaluation for immunoglobulin heavy chain gene rearrangement. Identical base-pair peaks were found, attesting to their clonal identity. This case represents a very unusual example of transformation of a low-grade FL to a nodular immunoblastic FL.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Centrocytic; Follicular lymphoma; Immunoblastic; Nodular; Transformation

Mesh:

Year:  2014        PMID: 25223592     DOI: 10.1016/j.humpath.2014.07.016

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  1 in total

1.  Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.

Authors:  Masashi Miyaoka; Yara Y Kikuti; Joaquim Carreras; Haruka Ikoma; Shinichiro Hiraiwa; Akifumi Ichiki; Minoru Kojima; Kiyoshi Ando; Tomoyuki Yokose; Rika Sakai; Masahiro Hoshikawa; Naoto Tomita; Ikuo Miura; Katsuyoshi Takata; Tadashi Yoshino; Jun Takizawa; Silvia Bea; Elias Campo; Naoya Nakamura
Journal:  Mod Pathol       Date:  2017-10-06       Impact factor: 7.842

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.